CODX vs TLRY · rev $3.9M vs rev $821.3M
Co-Diagnostics, Inc. Common Stock (CODX) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TLRY revenue for 2025-05-31 was $821.3M. Net income was -$2.18B. Revenue was up 4.1% from 2024-05-31 to 2025-05-31. TLRY currently screens at market cap $573.9M.
CODX currently screens at market cap $31.4M. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the CODX and TLRY stock pages for the full models.
Not investment advice.